UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Gain-of-Function Mutant p53 Promotes Cell Growth and Cancer Cell Metabolism via Inhibition of AMPK Activation

Molecular cell, 2014-06, Vol.54 (6), p.960-974

2014

Volltextzugriff (PDF)

Assembly and Initial Characterization of a Panel of 85 Genomically Validated Cell Lines from Diverse Head and Neck Tumor Sites

Clinical cancer research, 2011-12, Vol.17 (23), p.7248-7264

2011

Volltextzugriff (PDF)

Squamous Cell Carcinoma of the Oral Tongue in Young Non-Smokers Is Genomically Similar to Tumors in Older Smokers

Clinical cancer research, 2014-07, Vol.20 (14), p.3842-3848

2014

Volltextzugriff (PDF)

Melatonin-depleted blood from premenopausal women exposed to light at night stimulates growth of human breast cancer xenografts in nude rats

Cancer research (Chicago, Ill.), 2005-12, Vol.65 (23), p.11174-11184

2005

Volltextzugriff (PDF)

Sorafenib inhibits the angiogenesis and growth of orthotopic anaplastic thyroid carcinoma xenografts in nude mice

Molecular cancer therapeutics, 2007-06, Vol.6 (6), p.1785-1792

2007

Volltextzugriff (PDF)

Serine substitution of proline at codon 151 of TP53 confers gain of function activity leading to anoikis resistance and tumor progression of head and neck cancer cells

The Laryngoscope, 2013-06, Vol.123 (6), p.1416-1423

2013

Volltextzugriff (PDF)

HRAS mutations and resistance to the epidermal growth factor receptor tyrosine kinase inhibitor erlotinib in head and neck squamous cell carcinoma cells

Head & neck, 2014-11, Vol.36 (11), p.1547-1554

2014

Volltextzugriff (PDF)

Dual inhibition of epidermal growth factor receptor and insulin-like growth factor receptor I: Reduction of angiogenesis and tumor growth in cutaneous squamous cell carcinoma

Head & neck, 2011-02, Vol.33 (2), p.189-198

2011

Volltextzugriff (PDF)

Dim Light Adaptation Attenuates Acute Melatonin Suppression in Humans

Journal of biological rhythms, 2006-10, Vol.21 (5), p.394-404

2006

Volltextzugriff (PDF)

Mindfulness-based stress reduction for chronic pain conditions: Variation in treatment outcomes and role of home meditation practice

Journal of psychosomatic research, 2010, Vol.68 (1), p.29-36

2010

Volltextzugriff (PDF)

Epidermal Growth Factor Receptor (EGFR) Is Overexpressed in Anaplastic Thyroid Cancer, and the EGFR Inhibitor Gefitinib Inhibits the Growth of Anaplastic Thyroid Cancer

Clinical cancer research, 2004-12, Vol.10 (24), p.8594-8602

2004

Volltextzugriff (PDF)

Exome Sequencing of Head and Neck Squamous Cell Carcinoma Reveals Inactivating Mutations in NOTCH1

Science (American Association for the Advancement of Science), 2011-08, Vol.333 (6046), p.1154-1157

2011

Volltextzugriff (PDF)

An Orthotopic Nude Mouse Model of Oral Tongue Squamous Cell Carcinoma

Clinical cancer research, 2002-01, Vol.8 (1), p.293-298

2002

Volltextzugriff (PDF)

Cetuximab and Irinotecan Interact Synergistically to Inhibit the Growth of Orthotopic Anaplastic Thyroid Carcinoma Xenografts in Nude Mice

Clinical cancer research, 2006-01, Vol.12 (2), p.600-607

2006

Volltextzugriff (PDF)

The Tyrosine Kinase Inhibitor, AZD2171, Inhibits Vascular Endothelial Growth Factor Receptor Signaling and Growth of Anaplastic Thyroid Cancer in an Orthotopic Nude Mouse Model

Clinical cancer research, 2007-08, Vol.13 (15), p.4519-4527

2007

Volltextzugriff (PDF)

Integrin-linked kinase is a potential therapeutic target for anaplastic thyroid cancer

Molecular cancer therapeutics, 2005-08, Vol.4 (8), p.1146-1156

2005

Volltextzugriff (PDF)

Suppression of matrix metalloproteinase-2 gene expression and invasion in human glioma cells by MMAC/PTEN

Oncogene, 2001-10, Vol.20 (46), p.6669-6678

2001

Volltextzugriff (PDF)

Dual Epidermal Growth Factor Receptor and Vascular Endothelial Growth Factor Receptor Inhibition with NVP-AEE788 for the Treatment of Aggressive Follicular Thyroid Cancer

Clinical cancer research, 2006-06, Vol.12 (11), p.3425-3434

2006

Volltextzugriff (PDF)

Vandetanib Inhibits Growth of Adenoid Cystic Carcinoma in an Orthotopic Nude Mouse Model

Clinical cancer research, 2008-08, Vol.14 (16), p.5081-5089

2008

Volltextzugriff (PDF)

AEE788, a Dual Tyrosine Kinase Receptor Inhibitor, Induces Endothelial Cell Apoptosis in Human Cutaneous Squamous Cell Carcinoma Xenografts in Nude Mice

Clinical cancer research, 2005-03, Vol.11 (5), p.1963-1973

2005

Volltextzugriff (PDF)

An Orthotopic Murine Model of Sinonasal Malignancy

Clinical cancer research, 2008-11, Vol.14 (22), p.7348-7357

2008

Volltextzugriff (PDF)

Targeted molecular therapy of anaplastic thyroid carcinoma with AEE788

Molecular cancer therapeutics, 2005-04, Vol.4 (4), p.632-640

2005

Volltextzugriff (PDF)

Editor's Note: Epidermal Growth Factor Receptor (EGFR) Is Overexpressed in Anaplastic Thyroid Cancer, and the EGFR Inhibitor Gefitinib Inhibits the Growth of Anaplastic Thyroid Cancer

Clinical cancer research, 2019-08, Vol.25 (15), p.4862-4862

2019

Volltextzugriff (PDF)

Motif analysis of the tumor suppressor gene MMAC/PTEN identifies tyrosines critical for tumor suppression and lipid phosphatase activity

Oncogene, 2002-04, Vol.21 (15), p.2357-2364

2002

Volltextzugriff (PDF)

Targeted Therapy of VEGFR2 and EGFR Significantly Inhibits Growth of Anaplastic Thyroid Cancer in an Orthotopic Murine Model

Clinical cancer research, 2011-04, Vol.17 (8), p.2281-2291

2011

Volltextzugriff (PDF)

1 – 25 von 60

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(58)
Mit Volltextzugriff
(56)

Publikationsform

Artikel
(60)

Sprache

Englisch
(60)

Erscheinungsjahr

n.n

Thema

Science & Technology
(52)
Life Sciences & Biomedicine
(50)
Humans
(48)
Animals
(33)
Biological And Medical Sciences
(33)
Male
(32)
Mice
(31)
Oncology
(31)
Medical Sciences
(30)
Mice, Nude
(27)
Cell Line, Tumor
(16)
Pharmacology. Drug Treatments
(15)
Tumors
(15)
Antineoplastic Agents
(14)
Tumor Cells, Cultured
(13)
Blotting, Western
(12)
Cell Proliferation - Drug Effects
(12)
Carcinoma, Squamous Cell - Pathology
(11)
Female
(11)
Thyroid Neoplasms - Drug Therapy
(11)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Gain-of-Function Mutant p53 Promotes Cell Growth and Cancer Cell Metabolism via Inhibition of AMPK Activation

Assembly and Initial Characterization of a Panel of 85 Genomically Validated Cell Lines from Diverse Head and Neck Tumor Sites

Squamous Cell Carcinoma of the Oral Tongue in Young Non-Smokers Is Genomically Similar to Tumors in Older Smokers

Melatonin-depleted blood from premenopausal women exposed to light at night stimulates growth of human breast cancer xenografts in nude rats

Sorafenib inhibits the angiogenesis and growth of orthotopic anaplastic thyroid carcinoma xenografts in nude mice

Serine substitution of proline at codon 151 of TP53 confers gain of function activity leading to anoikis resistance and tumor progression of head and neck cancer cells

HRAS mutations and resistance to the epidermal growth factor receptor tyrosine kinase inhibitor erlotinib in head and neck squamous cell carcinoma cells

Dual inhibition of epidermal growth factor receptor and insulin-like growth factor receptor I: Reduction of angiogenesis and tumor growth in cutaneous squamous cell carcinoma

Dim Light Adaptation Attenuates Acute Melatonin Suppression in Humans

Mindfulness-based stress reduction for chronic pain conditions: Variation in treatment outcomes and role of home meditation practice

Epidermal Growth Factor Receptor (EGFR) Is Overexpressed in Anaplastic Thyroid Cancer, and the EGFR Inhibitor Gefitinib Inhibits the Growth of Anaplastic Thyroid Cancer

Exome Sequencing of Head and Neck Squamous Cell Carcinoma Reveals Inactivating Mutations in NOTCH1

An Orthotopic Nude Mouse Model of Oral Tongue Squamous Cell Carcinoma

Cetuximab and Irinotecan Interact Synergistically to Inhibit the Growth of Orthotopic Anaplastic Thyroid Carcinoma Xenografts in Nude Mice

The Tyrosine Kinase Inhibitor, AZD2171, Inhibits Vascular Endothelial Growth Factor Receptor Signaling and Growth of Anaplastic Thyroid Cancer in an Orthotopic Nude Mouse Model

Integrin-linked kinase is a potential therapeutic target for anaplastic thyroid cancer

Suppression of matrix metalloproteinase-2 gene expression and invasion in human glioma cells by MMAC/PTEN

Dual Epidermal Growth Factor Receptor and Vascular Endothelial Growth Factor Receptor Inhibition with NVP-AEE788 for the Treatment of Aggressive Follicular Thyroid Cancer

Vandetanib Inhibits Growth of Adenoid Cystic Carcinoma in an Orthotopic Nude Mouse Model

AEE788, a Dual Tyrosine Kinase Receptor Inhibitor, Induces Endothelial Cell Apoptosis in Human Cutaneous Squamous Cell Carcinoma Xenografts in Nude Mice

An Orthotopic Murine Model of Sinonasal Malignancy

Targeted molecular therapy of anaplastic thyroid carcinoma with AEE788

Editor's Note: Epidermal Growth Factor Receptor (EGFR) Is Overexpressed in Anaplastic Thyroid Cancer, and the EGFR Inhibitor Gefitinib Inhibits the Growth of Anaplastic Thyroid Cancer

Motif analysis of the tumor suppressor gene MMAC/PTEN identifies tyrosines critical for tumor suppression and lipid phosphatase activity

Targeted Therapy of VEGFR2 and EGFR Significantly Inhibits Growth of Anaplastic Thyroid Cancer in an Orthotopic Murine Model

Suchergebnisse filtern